1月17日,美国医疗保险和医疗补助服务中心宣布选择15种额外的药物,包括诺和诺德的减肥药Ozempic和Wegovy,用于医疗保险D部分的价格谈判。
诺和诺德美股盘前下挫,现跌超4%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.